Vori Health, a physician-led provider of musculoskeletal care, has announced a $53 million Series B funding round led by NEA, with participation from AlleyCorp, Intermountain Ventures, Echo Health Ventures, and Max Ventures. This oversubscribed round follows a period of strong performance, marked by an 800 percent increase in revenue and significant improvements in clinical outcomes. Since its Series A funding, the company has achieved a 91.6 percent patient-reported pain improvement rate, reduced elective orthopedic surgeries by up to 90 percent, decreased opioid use by 42 percent, and lowered depression and anxiety rates by up to 68 percent.
The new funding will support the nationwide expansion of Vori Health’s integrated care model, which includes board-certified physicians, therapists, dietitians, and coaches working as cohesive teams. The capital will also enhance Vori Health’s AI-driven technology platform and its advanced data analytics capabilities for identifying and managing high-risk patient populations. CEO Dr. Ryan Grant emphasized, "This investment marks a pivotal moment in our journey to deliver truly value-based musculoskeletal care at scale. The swift adoption of our platform by Fortune 200 companies and national health plans indicates that the market is primed for our comprehensive solutions." The company’s comprehensive approach aims to make musculoskeletal care more effective, accessible, and results-driven.
